Single Dose of Furosemide to Improve Respiratory Distress in Moderate to Severe Bronchiolitis
Completed · Phase 2 · Has a placebo group
Conditions studied: Bronchiolitis
In brief
The purpose of this study is to assess if administration of an early single dose of a diuretic (furosemide) to children with moderate to severe bronchiolitis can reduce extravascular lung water in an effort to reduce respiratory rate, retractions, intubations, and length of stay.
Key facts
- Study ID
- NCT02469597
- Run by
- Northwell Health
- People needed
- 46
- Starts
- 2013-10-01
- Expected to finish
- 2016-04-01
- Last updated by the study team
- 2016-08-12
Who can join
Age: any, up to 4. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Diagnosis of Acute Bronchiolitis
- Admission required per Emergency Department Physician
You may not qualify if…
- No legal guardian present
- Sulfa allergy
- Patient currently on existing diuretic therapy
- Tracheostomy
- Mild respiratory distress (not requiring admission)
- Hypotension / Hemodynamic Instability (defined by age specific criteria at time of intervention)
- Supplemental Oxygen at home
- History of Dialysis / Renal Disease
- Those enrolled in another drug interventional study
Where it is running
- Steven and Alexandra Cohen Children's Medical Center of New York — New Hyde Park, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.